biomarin
Details
-
Number of employees
1000-5000
About biomarin
BioMarin is a leading biotechnology company focused on developing therapies for rare diseases, particularly those that are genetically defined. Since its founding in 1997, the company has delivered a portfolio of innovative treatments for conditions such as achondroplasia, PKU, and various forms of mucopolysaccharidosis. With the recent acquisition of Amicus, BioMarin has expanded its offerings to include therapies for Fabry disease and Pompe disease, enhancing its ability to serve patients with rare genetic conditions.
Career Opportunities
BioMarin offers a dynamic work environment that fosters professional growth and collaboration among global teams. Employees benefit from a culture that prioritizes excellence and innovation, providing opportunities to make a significant impact on patient lives.
- Collaborative and inclusive work culture
- Opportunities for professional development and advancement
- Commitment to making a profound impact on patients' lives